Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
2.250
+0.220 (10.84%)
At close: Nov 20, 2026, 4:00 PM EST
2.340
+0.090 (4.00%)
After-hours: Nov 20, 2026, 7:58 PM EST
Evaxion Employees
Evaxion had 46 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Evaxion the 35,404th largest employer in the world and 4,736th in the United States.
Employees
46
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$162,848
Profits / Employee
-$188,152
Market Cap
20.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 46 | 0 | - |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Dec 31, 2023 | 49 | -14 | -22.22% |
| Dec 31, 2022 | 63 | 2 | 3.28% |
| Dec 31, 2021 | 61 | 26 | 74.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 107 |
| Adicet Bio | 102 |
| IGC Pharma | 70 |
| Aardvark Therapeutics | 28 |
| LeonaBio | 19 |
| ABVC BioPharma | 19 |
| CervoMed | 15 |
| TransCode Therapeutics | 12 |
EVAX News
- 1 day ago - Evaxion extends cash runway towards the end of 2027 after $2.2M share sales - TheFly
- 1 day ago - Evaxion Biotech refocuses strategy on immuno-oncology cancer vaccines - TheFly
- 1 day ago - Evaxion Biotech reports Q3 EPS (1c) vs. 1c last year - TheFly
- 1 day ago - Evaxion Earnings Call Transcript: Q3 2026 - Transcripts
- 1 day ago - Evaxion Earnings release: Q3 2026 - Filings
- 1 day ago - Evaxion Slides: Q3 2026 - Filings
- 1 day ago - Evaxion announces strategy and business update and third quarter 2026 financial results - GlobeNewsWire
- 2 days ago - Evaxion to announce strategy and business update and third quarter 2026 financial results on November 19, 2026 - GlobeNewsWire